Negative screening for 12 rare LRRK2 pathogenic variants in a cohort of Nigerians with Parkinson’s disease”, Neurobiology of Aging, Pp. 10-100000.
Early onset Parkinson’s disease screening in patients from Nigeria”, Frontiers of Neurology, Vol. 11,Issue 594927,Pp. 1-1 .
Profile of Non-motor symptoms and the association with the Quality of life of Parkinson’s disease patients in Nigeria”, Niger Med J, Vol. 60,Issue ,Pp. 267-272 .
A Nationwide survey of Parkinson’s disease medicines availability and affordability Nigeria”, Movement Disorders Clinical Practise, Vol. 1,Issue 1,Pp. 1-1 .
Leucine-Rich Repeat Kinase 2 (LARRK 2) Gly2019Ser Mutation is absent in a second cohort of Nigerian Africans with Parkinson’s disease”, PLOS ONE, Vol. 1,Issue ,Pp. 1-1 .
Primary headache disorders at a tertiary health facility in Lagos, Nigeria: Prevalence and consultation patterns”, Biomed Research International, Vol. 782915,Issue ,Pp. 1-6 . DOI.10.1155/2014/782915
Quality of sleep in an HIV population on antiretroviral therapy at an urban tertiary centre in Lagos, Nigeria”, Neurology Research International, Vol. 298703,Issue ,Pp. 1-6 .
New-onset seizures in HIV patients on antiretroviral therapy at a Tertiary centre in South-west, Nigeria”, World Journal of AIDS, Vol. 3,Issue ,Pp. 67-70 . DOI. 10.4236/wja.2013-32009
Influence of age and neurotoxic HAART use on frequency of HIV sensory neuropathy”, AIDS Research and Treatment, Vol. 961510,Issue ,Pp. 1-5 .
Comparison of the Mini-mental state examination scale and the International HIV dementia scale in assessing cognitive function in Nigerian HIV patients on antiretroviral therapy”, AIDS Research and Treatment, Vol. 581531,Issue ,Pp. 1-6 .